These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8682657

  • 21. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P, Danloy S, Deridder E, Lox M, Bernar H, Dhoest A, Collen D.
    J Clin Invest; 1998 Jul 15; 102(2):379-85. PubMed ID: 9664079
    [Abstract] [Full Text] [Related]

  • 22. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD, Molello JA, Caldwell WJ, Lebeau JE.
    Nouv Presse Med; 1980 Oct 30; 9(40):3005-7. PubMed ID: 7443440
    [Abstract] [Full Text] [Related]

  • 23. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y, Yan B, Fu M, Xu Y, Tian Y.
    Clin Chim Acta; 2005 Apr 30; 354(1-2):49-58. PubMed ID: 15748599
    [Abstract] [Full Text] [Related]

  • 24. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat.
    Felgines C, Mazur A, Rayssiguier Y.
    Life Sci; 1994 Apr 30; 55(13):1053-60. PubMed ID: 8084210
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W, Chen J, Redinger RN.
    J Investig Med; 1998 Dec 30; 46(9):460-9. PubMed ID: 9861782
    [Abstract] [Full Text] [Related]

  • 26. Expression of low density lipoprotein receptor, apolipoprotein AI, AII and AIV in various rat organs utilizing an efficient and rapid method for RNA isolation.
    Srivastava RA, Srivastava N, Schonfeld G.
    Biochem Int; 1992 Jun 30; 27(1):85-95. PubMed ID: 1378276
    [Abstract] [Full Text] [Related]

  • 27. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I, Sakamoto N, Nitatori R, Maeno H.
    Arzneimittelforschung; 1983 Jun 30; 33(2):237-41. PubMed ID: 6682662
    [Abstract] [Full Text] [Related]

  • 28. Concentrations of apolipoprotein AI, AII, and E in plasma and lipoprotein fractions of alcoholic patients: gender differences in the effects of alcohol.
    Lin RC, Miller BA, Kelly TJ.
    Hepatology; 1995 Apr 30; 21(4):942-9. PubMed ID: 7705804
    [Abstract] [Full Text] [Related]

  • 29. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC, Lamarche B, Deshaies Y, Tremblay AJ, Bergeron J, Gagné C, Couture P.
    Metabolism; 2008 Feb 30; 57(2):246-54. PubMed ID: 18191056
    [Abstract] [Full Text] [Related]

  • 30. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I.
    Clin Nutr; 2004 Jun 30; 23(3):401-7. PubMed ID: 15158304
    [Abstract] [Full Text] [Related]

  • 31. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 32. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased.
    Neele DM, Kaptein A, Huisman H, de Wit EC, Princen HM.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):374-8. PubMed ID: 9514936
    [Abstract] [Full Text] [Related]

  • 33. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ.
    Artery; 1982 Mar 17; 10(2):95-8. PubMed ID: 7092582
    [Abstract] [Full Text] [Related]

  • 34. Cyclosporin A inhibits apolipoprotein AI gene expression.
    Zheng XL, Wong NC.
    J Mol Endocrinol; 2006 Oct 17; 37(2):367-73. PubMed ID: 17032751
    [Abstract] [Full Text] [Related]

  • 35. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
    Hahn SE, Goldberg DM.
    Biochem Pharmacol; 1992 Feb 04; 43(3):625-33. PubMed ID: 1311585
    [Abstract] [Full Text] [Related]

  • 36. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K, Gartside PS, Hynd BA, Mendoza SG, Kashyap ML.
    Metabolism; 1985 Aug 04; 34(8):754-64. PubMed ID: 3927110
    [Abstract] [Full Text] [Related]

  • 37. [Fibrates].
    Yamada N.
    Nihon Rinsho; 2002 May 04; 60(5):962-7. PubMed ID: 12030000
    [Abstract] [Full Text] [Related]

  • 38. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
    Cheung MC, Wolf AC, Illingworth DR.
    Biochim Biophys Acta; 1992 Oct 30; 1128(2-3):244-9. PubMed ID: 1420297
    [Abstract] [Full Text] [Related]

  • 39. Effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO).
    Felgines C, Sérougne C, Mathé D, Mazur A, Lutton C.
    Life Sci; 1994 Oct 30; 54(5):361-7. PubMed ID: 8289597
    [Abstract] [Full Text] [Related]

  • 40. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD, Dietschy JM.
    J Cardiovasc Pharmacol; 1980 Oct 30; 2(3):281-97. PubMed ID: 6156326
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.